Immuneering Corp
SEC CIK 1790340 · IMRX · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Zeskind Benjamin J. | Director · President and CEO | filed 2021 - 2026 |
| Carpenter Robert J | Director | filed 2021 - 2026 |
| Schall Thomas J. | Director | filed 2024 - 2026 |
| Hausman Diane | Director | filed 2022 - 2026 |
| Keating Laurie | Director | filed 2021 - 2026 |
| Feinberg Peter | Director | filed 2021 - 2026 |
| Berman Ann E | Director | filed 2021 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hall Brett Matthew | Chief Scientific Officer | filed 2021 - 2026 |
| Neufeld Leah R | Chief People Officer | filed 2022 - 2026 |
| Matushansky Igor | Chief Medical Officer | filed 2025 - 2026 |
| Bookman Michael | General Counsel and Secretary | filed 2021 - 2026 |
| Morales Mallory | Vice President, Finance | filed 2022 - 2026 |
| Brakewood Harold Eugene | Chief Business Officer | filed 2023 - 2026 |
| Barrett Scott | Chief Medical Officer | filed 2021 - 2023 |
| Amin Biren | CFO, Treasurer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.